Opiranserin hydrochloride
Opiranserin hydrochloride is a dual GlyT2 and 5-HT2A receptor antagonist, also inhibiting the P2X3 receptor. It is an investigational injectable agent studied preclinically for its potential to modulate pain pathways, specifically for postoperative pain management.
Product Specifications
CAS Number
1440796-75-7
Product Name Alternative
Analgesic, anti-inflammatory, 5-HT Receptor, 5HTReceptor, 5HT Receptor, 5-hydroxytryptamine Receptor, Inhibitor, Glycine transporters, GlyT, GlyT2, inhibit, non-opioid, pain, Opiranserin, Opiranserin hydrochloride, Opiranserin Hydrochloride, P2X Receptor, P2XReceptor, P2XRs, Serotonin Receptor, postoperative, VVZ 149, VVZ149, VVZ-149
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
98.03% (May vary between batches)
Solubility
DMSO:50 mg/mL (116.02 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (4.64 mM)
Smiles
Cl.CCCCOc1c (OC) cc (cc1OC) C (=O) NCC1 (CCOCC1) N (C) C
Molecular Formula
C21H35ClN2O5
Molecular Weight
430.97
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
